Biotech FibroGen soars more than 50% on positive lung disease treatment study

The biotech company's drug pamrevlumab successfully completed a mid-stage Food and Drug Administration test.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>